Treating rheumatoid arthritis

British Medical Journal

Volumn 335, Issue 7610, 2007, Pages 56-57

  Emery, Paul ^a   Kvien, Tore K ^b  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRHEUMATIC AGENT; CORTICOSTEROID; DISEASE MODIFYING ANTIRHEUMATIC DRUG; INTERLEUKIN 1; METHOTREXATE; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR INHIBITOR; UNCLASSIFIED DRUG; TUMOR NECROSIS FACTOR ALPHA;

BONE RADIOGRAPHY; COST EFFECTIVENESS ANALYSIS; DISEASE COURSE; DRUG EFFECT; DRUG EFFICACY; DRUG TOLERABILITY; EDITORIAL; HUMAN; MONOTHERAPY; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; REMISSION; RHEUMATOID ARTHRITIS;

ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; HUMANS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 34447626983     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.39265.679375.80     Document Type: Editorial

References (0)